经皮冠状动脉介入治疗术后出血风险评估研究进展  

Bleeding Risk Assessment After Percutaneous Coronary Intervention

作　　者：刘娟 熊诗强[2] 蔡琳 LIU Juan;XIONG Shiqiang;CAI Lin(Department of Cardiology,Anzhou District People’s Hospital of Mianyang,Mianyang 621000,Sichuan,China;Department of Cardiology,The Third People’s Hospital of Chengdu,Chengdu 610031,Sichuan,China)

机构地区：[1]绵阳市安州区人民医院心内科,四川绵阳621000 [2]成都市第三人民医院心内科,四川成都610031

出　　处：《心血管病学进展》2023年第4期303-307,311,共6页Advances in Cardiovascular Diseases

摘　　要：经皮冠状动脉介入治疗(PCI)是一种广泛应用的获得心肌血运重建的策略。PCI术后的抗栓治疗已成为治疗冠心病的基石,能有效防止支架内血栓形成和缺血事件的发生。然而与抗栓治疗相关的各种出血并发症也成为关注的热点。目前已有多个出血评分系统可用于预测患者在不同时期的出血风险,指导临床医生更全面地评估PCI术后出血风险,改善患者预后。现将出血风险评估模型结合其临床应用及最新研究进展做一综述,为临床实践提供参考。Percutaneous coronary intervention(PCI)is a widely adopted strategy to obtain myocardial revascularization in patients.Antithrombotic therapy after PCI has become the cornerstone of drug therapy for acute coronary syndrome,which can effectively prevent stent thrombosis and ischemic events.However,various bleeding complications related to antithrombotic therapy have also become a hot spot of concern.At present,several bleeding scoring systems can be used to predict the bleeding risk of patients at different periods,guide clinicians to more comprehensively evaluate the bleeding risk after PCI,and improve the prognosis of patients.This article reviews the bleeding risk assessment model combined with its clinical application and the latest research progress,so as to provide reference for clinical practice.

关 键 词：经皮冠状动脉介入治疗 抗血小板治疗 出血风险评分 

分 类 号：R541.4[医药卫生—心血管疾病]